BROADWAY PRODUCTS (as PLD) - DR. PIERCING AFTERCARE MEDICATION SPRAY (81926-101)

DR. PIERCING AFTERCARE MEDICATION by

Drug Labeling and Warnings

DR. PIERCING AFTERCARE MEDICATION by is a Otc medication manufactured, distributed, or labeled by Broadway Products LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DR. PIERCING AFTERCARE MEDICATION- benzalkonium chloride spray 
Broadway Products LLC

----------

BROADWAY PRODUCTS (as PLD) - DR. PIERCING AFTERCARE MEDICATION SPRAY (81926-101)

ACTIVE INGREDIENT

BENZALKONIUM CHLORIDE 0.11%

PURPOSE

ANTISEPTIC

USES

FOR CLEANING PIERCINGS AND MINOR WOUNDS.

DIRECTIONS

• TWIST THE CAP TO UNLOCK
• BEFORE USE, SPRAY IN AIR OR AWAY FROM WOUND TO TEST FLOW AND CLEAN NOZZLE HEAD
• TO APPLY, AIM NOZZLE AT AREA OF INTEREST FROM DESIRED DISTANCE AND SPRAY UNTIL DESIRED AMOUNT IS APPLIED

WARNINGS

• DO NOT USE IF TAMPER BAN IS REMOVED
• DO NOT USE IN BODY ORIFICES, EAR CANALAS OR EYES.
• CONSULT A HEALTHCARE PROFESSIONAL FOR CONTINUED WOUND CARE AND FOR USE ON CHILDREN
• IF SWELLING, REDNESS OR PAIN INCREASES, PLEASE SEEK THE ADVICE OF YOUR HEALTHCARE PROFESSIONAL
• STORE IN A COOL ENVIRONMENT AT 59 F TO 86 F AND PROTECTED FROM SUNLIGHT
• CONTENT UNDER PRESSURE
• FOR EXTERNAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

OTHER INGREDIENTS

CAPB, ISOTONIC SALINE SOLUTION, SODIUM CHLORIDE, ALLANTOIN, ALOE VERA, KATHHOC CG II, PRO-VITAMIN B5, TRIETHANOLAMINE

DR. PIERCING AFTERCARE MEDICATION 
benzalkonium chloride spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81926-101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	0.11 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ISOTONIC SODIUM CHLORIDE SOLUTION (UNII: VR5Y7PDT5W)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PANTOTHENIC ACID (UNII: 19F5HK2737)
TROLAMINE (UNII: 9O3K93S3TK)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
ALLANTOIN (UNII: 344S277G0Z)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE MIXTURE (UNII: 15O9QS218W)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81926-101-74	74 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	08/04/2022	03/01/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M003	08/04/2022	03/01/2024

Labeler - Broadway Products LLC (002672936)

Revised: 12/2024

Document Id: 29a3f3a7-5d3e-643f-e063-6294a90aa1ce

34390-5

Set id: e5701f7b-54e6-7a09-e053-2a95a90aa337

Version: 6

Effective Time: 20241219